TIFFANI BOTTS: Open Payments
NPI 1316327877 · ST PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,725 in 42 payments from 15 companies in 2025. Trend: 2023 $3,191 · 2024 $2,397 · 2025 $3,725
Food & beverage: $1,940Speaker / faculty: $1,085Consulting: $700
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 10 | $1,227 |
| Botanix SB Inc | 1 | $700 |
| ABBVIE INC. | 9 | $445 |
| Regeneron Healthcare Solutions, Inc. | 2 | $272 |
| Incyte Corporation | 5 | $167 |
| Madrigal Pharmaceuticals | 1 | $148 |
| Janssen Biotech, Inc. | 1 | $145 |
| Organon LLC | 1 | $139 |
| Teva Pharmaceuticals USA, Inc. | 1 | $121 |
| MERZ NORTH AMERICA, INC. | 4 | $116 |
Products named: SOFDRA, DUPIXENT, BOTOX, REZDIFFRA, RINVOQ, TREMFYA, VTAMA, OPZELURA.
Industry payments across FL — which companies pay providers there.
